Medicine
Weltruza kit
Weltruza kit is a prescription medicine containing Olanzapine for subcutaneous use, marketed by Teva Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store WELTRUZA in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original…
Key facts
- Active ingredient (INN)
- Olanzapine
- Brand
- Weltruza
- Dosage form
- Kit
- Route
- Subcutaneous
- Packs
- 1 kit
- Marketing authorisation holder
- Teva Pharmaceuticals
- Manufacturer
- Teva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store WELTRUZA in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton. Unopened WELTRUZA may be stored at room temperature, 20°C to 25°C (68°F to 77°F), for a single period of up to 90 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH03 Olanzapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 November 2026
- Identifiers
- DailyMed set ID a23e99c7-fb76-46d2-95af-e03d5a4d1f2cNDC 51759-349, 51759-347, 51759-348Application NDA219007
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * .9 mL in 1 vial * 1.1 mL in 1 syringe | 51759-347-50 | Teva Pharmaceuticals | 2 November 2026 |
| 1 kit in 1 carton * 1.2 mL in 1 vial * 1.3 mL in 1 syringe | 51759-348-50 | Teva Pharmaceuticals | 2 November 2026 |
| 1 kit in 1 carton * 1.5 mL in 1 vial * 1.5 mL in 1 syringe | 51759-349-50 | Teva Pharmaceuticals | 2 November 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Olanzapine kit.
Other strengths and forms of Olanzapine
Clinical summary
Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as tablets, orally disintegrating tablets and powder for injection for intramuscular and subcutaneous use. MedsAcross supplies Olanzapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlanzapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zyprexa prescribing information (H2-Pharma) · U.S. National Library of Medicine, DailyMed
- Zypadhera: European public assessment report (EPAR) · European Medicines Agency
- Zyprexa Velotab: European public assessment report (EPAR) · European Medicines Agency
Need Weltruza kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.